tgtx sales：TG Therapeutics, Inc. (TGTX) Stock Price
TG Therapeutics, Inc. (TGTX) Stock Price
SalesofTGTherapeutics'highlyanticipatedmultiplesclerosisdrug,Briumvi,missedforecastsonTuesdayandTGTXstockplummeted.。其他文章還包含有：「TGTherapeuticsProvidesBusinessUpdateandReports...」、「TGTherapeuticsProvidesBusinessUpdateandReportsFirst...」、「TGTherapeutics|TGTX」、「TGTherapeutics」、「TGTherapeutics」、「TGTherapeutics」、「TGTherapeutics」、「TGTherapeutics」、「TGTXSep202313.500ca...
查看更多 離開網站
TG Therapeutics Provides Business Update and Reports ...
https://finance.yahoo.com
Second quarter 2023 BRIUMVI® net sales of $16 million in the United ... 01, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) ...
TG Therapeutics Provides Business Update and Reports First ...
https://ir.tgtherapeutics.com
First quarter 2023 BRIUMVI net sales of $7.8 million. Over 400 BRIUMVI prescriptions in the first partial quarter from 165+ healthcare ...
TG Therapeutics | TGTX
https://tradingeconomics.com
TG Therapeutics reported $16.07M in Sales Revenues for its fiscal quarter ending in June of 2023. ; TG Therapeutics TGTX:US, USD 16.07M · 8.27M · Jun/2023 ; Vertex ...
TG Therapeutics
https://finance.yahoo.com
TGTX - TG Therapeutics, Inc. ; Year Ago Sales, 94k, 80k, 2.79M · 143.98M ; Sales Growth (year/est), 53,219.10%, 48,700.00%, 5,069.80%, 94.60% ...
TG Therapeutics
https://finance.yahoo.com
Get the latest TG Therapeutics, Inc. (TGTX) stock news and headlines to help you in ... Second quarter 2023 BRIUMVI® net sales of $16 million in the United ...
TG Therapeutics
https://finance.yahoo.com
Sales of TG Therapeutics' highly anticipated multiple sclerosis drug, Briumvi, missed forecasts on Tuesday and TGTX stock plummeted.
TG Therapeutics
https://finance.yahoo.com
Get the latest insider transactions for TG Therapeutics, Inc. (TGTX). Find out the total of insider shares held, ... Sale at price 18.31 - 19.20 per share.
TG Therapeutics
https://seekingalpha.com
Many are predicting sales to have grown exponentially - from ~$8m in Q123 - when next quarter's earnings are announced.
TGTX Sep 2023 13.500 call
https://finance.yahoo.com
Sales of TG Therapeutics' highly anticipated multiple sclerosis drug, Briumvi, missed forecasts on Tuesday and TGTX stock plummeted.